Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Quotient Clinical at AAPS 2013

Published: Friday, November 08, 2013
Last Updated: Friday, November 08, 2013
Bookmark and Share
AAPS annual meeting and exposition to be held in San Antonio, Texas, from the 10th to the 14th of November.

Quotient Clinical will be showcasing the benefits of its unique, integrated approach to formulation development, real-time manufacturing and clinical testing on booth 2800 at this year’s American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition.

Held in San Antonio, Texas, from the 10th to the 14th of November, this meeting will provide delegates with the opportunity to see some of the latest developments in the pharmaceutical sector, including a variety of projects which have benefitted from the reduced costs and faster time-to-market offered by Quotient Clinical’s innovative development platform.

Quotient Clinical will be supporting several other activities and events at the meeting, including a RapidFACT™ user group meeting and six poster presentations.

The RapidFACT user meeting will aim to build on last year’s highly successful event, and will include a number of customer presentations, as well as an open forum to discuss various aspects of the RapidFACT process.

On the final day of the conference, Dr Alyson Connor, Director of Exploratory Clinical Pharmacology at Quotient Clinical, will be participating in a symposium featuring a number of prominent speakers from academia and industry entitled Understanding in vivo dissolution: can imaging tools provide the missing link?

Alyson will be discussing the practicalities of tracking oral dosage form performance using scintigraphic imaging, and participating in a panel discussion on the use of imaging tools in pharmaceutical research.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Quotient Prepares for the Japenese Market
Announcement confirms the completion of Quotients first clinical program involving Japanese healthy volunteers.
Wednesday, March 16, 2016
Quotient Clinical Celebrates its 100th RapidFACT® Program
Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has completed its 100th RapidFACT (Rapid Formulation development And Clinical Testing) program – a significant milestone in the growth of this service, which addresses drug R&D productivity issues.
Wednesday, February 10, 2016
Quotient Clinical Acquires Co-Formulate
Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has acquired formulation development specialist Co-Formulate Limited.
Thursday, December 17, 2015
Quotient Clinical Acquired by GHO Capital
Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has been acquired by specialist healthcare investor GHO Capital, with financial details of the transaction remaining undisclosed.
Thursday, December 03, 2015
Quotient Clinical Begins Prostate Cancer Project for Druggability Technologies
The program will assess new formulations using DRGT’s proprietary Super-API technology, and aims to reduce dose and address food effects associated with the drug.
Wednesday, June 24, 2015
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Thursday, April 23, 2015
Quotient Clinical Announces ADME Success in Oncology
Company to supply 14C radiolabelled drug products to specialist oncology clinics globally.
Thursday, April 02, 2015
Quotient Clinical Showcases ‘Gold Standard’ Human ADME Studies and Applications
Company will present a symposium and three poster publications at ISSX/JSSX 2014.
Wednesday, September 24, 2014
Quotient Clinical Celebrates its 50th RapidFACT™ Program
The 50th Rapid Formulation development And Clinical Testing program marks a significant milestone in the development of this service.
Thursday, February 06, 2014
Quotient Clinical Announces New Investment In Translational Pharmaceutics™
The investment represents a significant expansion of Quotient's capacity and capabilities.
Tuesday, November 19, 2013
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Study Identifies How Brain Connects Memories Across Time
UCLA Neuroscientists have boost ability of aging brain to recapture links between related memories.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!